Seven Eight Capital, LP Pacira Bio Sciences, Inc. Transaction History

Seven Eight Capital, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$51.97 - $63.0 $389,775 - $472,500	-7,500 Closed	0 $0
Q2 2020 Aug 06, 2020	BUY	$30.8 - $52.47 $231,000 - $393,525	7,500 New	7,500 $394,000
Q1 2020 May 14, 2020	SELL	$28.4 - $50.7 $451,162 - $805,420	-15,886 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$36.31 - $46.83 $602,346 - $776,862	-16,589 Reduced 51.08%	15,886 $720,000
Q3 2019 Nov 14, 2019	BUY	$35.66 - $44.99 $78,451 - $98,978	2,200 Added 7.27%	32,475 $1.24 Million
Q2 2019 Aug 12, 2019	BUY	$36.57 - $47.97 $1.11 Million - $1.45 Million	30,275 New	30,275 $1.32 Million
Q4 2018 Feb 14, 2019	SELL	$41.31 - $52.16 $259,220 - $327,304	-6,275 Closed	0 $0
Q3 2018 Oct 18, 2018	BUY	$32.85 - $52.0 $206,133 - $326,300	6,275 New	6,275 $308,000
Q3 2017 Oct 16, 2017	SELL	$35.7 - $39.5 $34,164 - $37,801	-957 Closed	0 $0
Q2 2017 Aug 10, 2017	BUY	N/A	957	957 $46,000

266

50.6M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $761M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Seven Eight Capital, LP with notifications on news.